Another Challenge For David

He planned to cycle 1000km in thirty days in the heat and humidity of Singapore to raise money for Secondary1st. In the first two days he covered more than 80 km so he was well on track to complete his challenge. Then a sudden flare-up of a health issue meant that David had to have…

Good Results From Parp Inhibitor Trial

A drug trial for Olaparib, also known as Lynparza, has shown good results for women with breast cancer who have faulty variants in BRCA1 or BRCA2 genes. In the trial 85.9% of women given Olaparib for one year after the end of treatment showed no return of the cancer for three years, compared with77.1% of…